Search:

Exact Keyword


Total 605 results.
Sort by Relevant
Global Markets for Arthroscopy, Bronchoscopy, ENT Endoscopy, Neuroendoscopy, and Spinal Endoscopy (2015)
109 Pages | 73 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
Robust growth is expected for sales of minimally invasive surgical products through 2020. The market, which was valued at $8.4 billion in 2014 and includes arthroscopes, bronchoscopes, endoscopes, instrumentation, access devices, and related products is benefiting from the adoption of new devices and techniques that expand the range of surgical caseloads; patient and clinical preference for less-invasive surgical methods; and rising access to advanced technologies in emerging markets. This an...[Read More]




U.S. Markets for Advanced Wound Care Products (2015)
143 Pages | 31 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
Over the past 20 years, there has been an explosion of knowledge regarding the basic science of wound healing and a trend toward more evidence-based medicine. Advanced wound care technologies that have been developed include tissue-engineered skin replacement/substitutes, active wound repair modulators, advanced wound closure products, and advanced wound dressings. This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and oppo...[Read More]




Emerging Global Markets for Novel Peripheral Interventional and Neurointerventional Therapeutic Systems (2015)
189 Pages | 49 Exhibits | 2015 Analysis | Forecasts Through 2018 | Relavancy 1
Peripheral vascular disease and acute stroke are major public health problems worldwide, and the incidence and prevalence of these conditions is rising, reflecting both the aging of the population in many regions of the world, and continuing growth in the incidence of problematic risk factors such as diabetes, hypertension and obesity. In recent years, device manufacturers have developed a number of novel and highly promising percutaneous revascularization technologies including peripheral d...[Read More]




Global Markets for Drug Delivery: Infusion and Injection Technologies (2015)
111 Pages | 71 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
Infusion and injection technologies generated $14.2 billion in global sales during 2014. As discussed in LSI's new report, "Global Markets for Drug Delivery: Infusion and Injection Technologies in 2015," the market for these products-which include infusion systems, vascular access devices, and injection products- will be affected by critical regional factors that include initiatives to expand access to healthcare, limit the cost of expensive critical and long-term care, and improve convenienc...[Read More]




2015 Opportunities in Global Medical Devices & Diagnostics (2015)
557 Pages | 200 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
The $379 billion global medical devices and diagnostics (MD&D) industry has been undergoing significant globalization and consolidation as industrialized nations seek to provide more care for fewer dollars and emerging nations strive to better serve the health care needs of new urban classes driving their economic growth. Although market growth is unlikely to return to former double-digit levels, significant opportunities in new technologies, geographies and strategic merger & acquisition (M&...[Read More]




2015 Worldwide Markets and Emerging Technologies for Point-of-Care Testing (2015)
307 Pages | 129 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
The market for point-of-care (POC) diagnostic products comprises 28% of the total in-vitro diagnostics market. The market is projected to grow at a considerably slower rate than the overall IVD market over the 2014-2019 interval, primarily due to stagnant sales in the whole blood glucose self-testing segment, which accounts for more than half (53%) of the total market. However, most other segments of the POC diagnostics market are growing at rates well in excess of the overall POC market, and...[Read More]




U.S. Markets for Orthopedic Biologic and Tissue Engineered Products (2015)
116 Pages | 27 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
Biologics and cellular therapies for musculoskeletal injuries-including hard tissue (i.e., bone) and soft tissue (i.e., cartilage, ligaments, and tendons)-represent a billion dollar market that is showing the potential for continued growth. Over the forecast period covered in this report, the estimated value of the U.S. market for orthopedic biologic and tissue engineered products is expected to grow by approximately $984.4 million at a compound annual growth rate (CAGR) of 8.2%; of this hol...[Read More]




Global Markets for Peripheral Endovascular and Vascular Closure Devices (2015)
344 Pages | 171 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
Percutaneous transluminal angioplasty will lead the way with double-digit annual growth, driving expansion in U.S. and international markets. Robust market growth is expected for several peripheral endovascular and vascular closure devices on a global basis. Endovascular therapies have seen rising adoption due to new product introductions, the increasing prevalence of peripheral artery disease, developing healthcare systems in emerging markets, and the desire to utilize minimally invasive...[Read More]




Global Markets for Surgical Drapes, Gowns, Gloves, Masks, and Fluid Management Products (2015)
94 Pages | 46 Exhibits | 2015 Analysis | Forecasts Through 2020 | Relavancy 1
The global market for surgical drapes and gowns, gloves, masks, and fluid management products was valued at $9.5 billion in 2014. As analyzed in this detailed new analysis by LSI, the market will be influenced by efforts to limit health care costs through the reduction of infections and product expenditures as well as the need to accommodate the rising number of surgeries in key markets. Trends in product utilization, such as double-gloving, will generate growth in the number of units sold ea...[Read More]




International Markets for Specialty Peripheral Vascular Products (2015)
85 Pages | 41 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
The international market for atherectomy products, chronic total occlusion devices, balloon catheters, and embolic protection devices was valued at $733 million during 2013. This new report from Life Science Intelligence explores the market for these devices in Europe, Asia-Pacific and the rest of the world and analyzes key factors influencing the international market, such as how clinical studies in support of product approvals in the U.S. could affect uptake and utilization in Europe; the e...[Read More]




U.S. Markets for Specialty Peripheral Vascular Products (2015)
72 Pages | 31 Exhibits | 2015 Analysis | Forecasts Through 2019 | Relavancy 1
Atherectomy products, chronic total occlusion devices, balloon catheters, and embolic protection devices accounted for $836 million in U.S. sales during 2013. As discussed in Life Science Intelligence's new report, strong growth is expected in the U.S. market in coming years due to clinical efforts to improve the effectiveness of interventional methods for treating peripheral artery disease (PAD); attempts to refine techniques; and the impact of new products such as drug-coated balloons (DCBs...[Read More]




U.S. Markets for Critical Care Patient Management Products (2014)
179 Pages | 50 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
Critical care in the U.S. is expanding rapidly, particularly as hospital lengths of stay decrease, and the intensity of care and acuity of patients admitted to hospitals increase. Hospitals are evolving into critical care centers to which only the most seriously ill patients are admitted. Virtually every hospital unit has a significant percentage of patients benefiting from advanced technologies and equipment necessary for sustaining life, or for rapidly identifying severe clinical conditio...[Read More]




U.S. Markets for Respiratory Care Products (2014)
200 Pages | 67 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
In the United States (U.S.), more than 35 million people suffer from some form of respiratory disorder and 1 in 6 deaths are caused by chronic lung disease. According to the American Lung Association, the annual economic burden of lung disease in the U.S. is estimated at $154 billion, consisting of $95 billion in direct healthcare costs and $59 billion in indirect costs including lost work days. This dynamic new report from Medtech Insight includes analyses of products, current/forecast...[Read More]




U.S. Markets for Interventional Technologies for the Management of Peripheral Vascular Disorders (2014)
273 Pages | 62 Exhibits | 2014 Analysis | Forecasts Through 2017 | Relavancy 1
Peripheral vascular disease (PVD) refers to those conditions that affect the vessels carrying blood to and from the extremities as well as the tissues and organs of the abdominal and pelvic cavities. The most commonly diagnosed form of PVD is plaque-related peripheral artery disease; among the other types of PVD are chronic venous insufficiency, deep vein thrombosis, and pulmonary embolism. In 2012, approximately 3.8 million interventional procedures for the diagnosis and treatment ...[Read More]




U.S. Markets for Neurosurgical and Neurointerventional Products (2014)
116 Pages | 36 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
This dynamic, new report from Medtech Insight includes analyses of selected products, current/forecast markets, surgical procedure volumes, competitors, market share by supplier, and opportunities in the U.S. Neurosurgical and Neurointerventional Products Market. Specifically, this report covers neurosurgical, neurointerventional and image-guided surgical navigation and brain radiotherapy systems used for the treatment of several acute and chronic disorders such as benign and malignant neopla...[Read More]




U.S. Markets for Specialty Endoscopic Surgery Products (2014)
173 Pages | 59 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
Over the past several decades, a revolutionary transition has occurred among many surgical procedures that has taken them from an invasive open approach to minimally invasive/endoscopic methods due to advances in medical technology and surgical techniques. The adoption of endoscopy for many procedures has greatly benefited patients, as it reduces pain, recovery time, and scarring as well as hospital costs. The emergence of small-incision and incisionless procedures has resulted in the avail...[Read More]




U.S. Cancer Statistics Update 2014 (2014)
76 Pages | 18 Exhibits | 2014 Analysis | Forecasts Through | Relavancy 1
Cancer is the second-leading cause of death in the United States (U.S.) after heart disease. It is estimated that in 2014 nearly 1.7 million people in the country will be diagnosed with cancer and that approximately 585,720 will die from the disease in the same year. This new report from Medtech Insight includes statistics for new cancer cases, prevalence, and deaths due to the disease in 2014. Covered topics in this report include an overview of cancer in the U.S. including discus...[Read More]




European Markets for Spinal Motion-Preserving Devices (2014)
171 Pages | 43 Exhibits | 2014 Analysis | Forecasts Through 2017 | Relavancy 1
An estimated 34 million people in the 5 major European Union markets (France, Germany, Italy, Spain, and the United Kingdom) and the Benelux and Nordic regions suffer from chronic back pain, and the incidence is expected to increase over the next several years, largely due to an expanding elderly population and the growing incidence of degenerative disc disease. This dynamic new report from Medtech Insight includes analyses of products, current/forecast markets, competitors, and opportuni...[Read More]




U.S. Markets for Oncology-Related Diagnostic Ultrasound, Minimally Invasive Biopsy, and Tissue Screening Products (2014)
261 Pages | 38 Exhibits | 2014 Analysis | Forecasts Through 2017 | Relavancy 1
Cancer is the second-leading cause of death in the United States (U.S.) after heart disease. It is estimated that nearly 1.7 million people in the country will be diagnosed with cancer in 2014, and that approximately 585,720 will die from the disease. In the fight against cancer, diagnostic ultrasound imaging, minimally invasive biopsy, and tissue screening are among the methods that allow physicians to detect malignancies at their earliest and most treatable stages. In 2012, approximate...[Read More]




International Markets for Vascular Access Site Closure Devices (2014)
179 Pages | 58 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
Every 34 seconds someone in the U.S. will suffer a coronary event, and every 83 seconds someone will die from such an event. In the next decade, the number of people living in the U.S. who have coronary and peripheral vascular disease is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic disorders such as cardiovascular disease, diabetes, and obesity. Currently, 15.4 million adults age 20 or older in...[Read More]




U.S. Surgical Procedure Volumes (2014)
410 Pages | 95 Exhibits | 2014 Analysis | Forecasts Through 2019 | Relavancy 1
The number of laparoscopic/percutaneous surgical procedures performed in the United States (U.S.) has been gradually expanding over the years, reflecting the steady migration of patients from acute care settings and open surgery. By the end of 2010, outpatient procedures accounted for more than 50% of all surgeries performed in the U.S., compared with an estimated 30% in 2000. This trend is expected to continue over the forecast period covered by this report, though at a somewhat slower pac...[Read More]




Global Markets for Assisted Breathing, Airway Management, and Ventilation in 2014 (2014)
137 Pages | 80 Exhibits | 2014 Analysis | Forecasts Through 2019 | Relavancy 1
Ventilators and airway management products generated $4.8 billion in global revenues during 2013. As discussed extensively in LSI\'s new report, the global market for these products will be affected by key regional differences. In the U.S., where respiratory caseloads are expected to rise, greater preference will be given to systems that enable use for patients at all levels of acuity as well as those that facilitate the transition from costly intensive care settings. The European market will...[Read More]




U.S. Disease Incidence and Prevalence (2014)
380 Pages | 122 Exhibits | 2014 Analysis | Forecasts Through | Relavancy 1
This comprehensive report examines the etiology and epidemiology, number of hospital discharges, incidence and prevalence, and mortality rates of the most prevalent diseases/disorders in the United States for the years 2000-2010, and 2013. Categories covered by this report include: Blood disorders (anemia and hemophilia); Cancer (breast, colon/rectum, lung, nervous system, ovaries, pancreas, prostate, and skin); Cardiovascular diseases/disorders (atherosclerosis, heart failure, high blo...[Read More]




Global Markets for Neonatal/Perinatal Monitoring and Treatment Products in 2014: Infant Warmers and Incubators (2014)
84 Pages | 37 Exhibits | 2014 Analysis | Forecasts Through 2019 | Relavancy 1
Infant warmers, incubators, and hybrid systems generated $486 million in global revenues during 2013. The market for these devices, which is analyzed in LSI\'s new report, will continue to be shaped by regional and local trends in annual births and the delivery of neonatal care. As such, it will differ strikingly between developed and emerging markets, especially in countries where many births continue to take place outside of healthcare institutions; furthermore, limited purchasing resources...[Read More]




2014 Global Opportunities in Medical Devices & Diagnostics (2014)
550 Pages | 154 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
The global medical devices and diagnostics (MD&D) market made further albeit modest progress in 2013-growing 2.0% to $365 billion-despite continued capital constraints and global economic challenges. Europe saw a modest rebound, whereas growth slowed considerably in the Asia-Pacific region as those nations regrouped. Acquisitions, many of which further consolidated the industry, continued as companies sought to increase sales and expand their penetration of focal and emerging segmen...[Read More]




U.S. Markets for Interventional Cardiology Products (2014)
270 Pages | 68 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
Every 34 seconds someone in the U.S. will suffer a coronary event, and every 83 seconds someone will die from such an event. In the next decade, the number of people living in the U.S. who have heart conditions is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic disorders such as cardiovascular disease, diabetes, and obesity. Currently, 15.4 million adults age 20 or older in the U.S. suffer from co...[Read More]




U.S. Markets for Sports Medicine Products (2014)
176 Pages | 52 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
Each year in the U.S., approximately 30 million children and teens participate in organized sports, and more than 200 million adults participate in non-work-related sports or recreational activities. Although these activities are generally beneficial to one\'s health, they do involve the risk of injury and associated healthcare costs. Each year, nearly 5 million people in the U.S. receive medical treatment for sports injuries including sprains/strains, dislocations/fractures, knee injuries,...[Read More]




France, Disease Incidence and Prevalence (2014)
236 Pages | 22 Exhibits | 2014 Analysis | Forecasts Through | Relavancy 1
As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of many major diseases/disorders are expected to increase accordingly and significantly impact the European healthcare industry. This dynamic new report from Medtech Insight examines the incidence and prevalence of selected diseases/disorders in France. Incidence and prevalence figures are for the year 2012, the most recent year for which data are available. This report is th...[Read More]




U.S. Markets for Diagnostic Oncology-Related Magnetic Resonance and Nuclear/Molecular Medicine Imaging Systems (2014)
180 Pages | 37 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
It is estimated that nearly 1.7 million people in the United States (U.S.) will be diagnosed with cancer in 2014, and that approximately 585,720 will die from the disease. Despite advancements in oncology (the branch of medicine that deals with cancer), the disease remains the second-leading cause of death in the country after heart disease. Today, a constellation of methods are used in the fight against cancer, including diagnostic imaging modalities such as magnetic resonance imaging (MRI...[Read More]




U.S. Markets for Invasive and Noninvasive Diagnostic Cardiology Products (2014)
264 Pages | 66 Exhibits | 2014 Analysis | Forecasts Through 2018 | Relavancy 1
In the next decade, the number of people living in the United States (U.S.) with diseases/disorders of the heart and vascular system is expected to continue to increase along with expansion in the elderly segment of the population and growth in the number of people with chronic conditions such as cardiovascular disease (CVD), diabetes, and obesity, which are exacerbated by unhealthful behaviors such as physical inactivity and tobacco smoking. Diagnostic interventional cardiology procedur...[Read More]




Contact Us

Need help finding medtech research? Let us help you!